12:00 AM
Sep 17, 2012
 |  BC Week In Review  |  Clinical News  |  Preclinical Results

NanoViricides preclinical data

In mice lethally infected with H1N1 virus, 2 FluCide candidates given once daily orally significantly increased plasma anti-influenza antibody levels vs. Tamiflu oseltamivir (1,866 and 1,491 µg/mL, respectively,...

Read the full 129 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Week In Review

Article Purchase

$35 USD
More Info >